Burns
Volume 33, Issue 1 , Pages 81-86 , February 2007

Effects of gabapentin on morphine consumption and pain in severely burned patients

  • Olivier Cuignet

      Affiliations

    • Burn Center, Military Hospital, Rue Bruyn 1, 1120 Brussels, Belgium
  • ,
  • Jean Pirson

      Affiliations

    • Burn Center, Military Hospital, Rue Bruyn 1, 1120 Brussels, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32 2 2644810.
  • ,
  • Olivier Soudon

      Affiliations

    • Department of Anesthesiology, Université Catholique de Louvain, Belgium
  • ,
  • Martin Zizi

      Affiliations

    • ACOS WB, Division of Biostatistics and Epidemiology, Belgian Ministry of Defense, Belgium

,Accepted 18 April 2006.

  • Image Result

    Mean daily pain scores. (a) During the 21 days of treatment with 800mg of oral gabapentin three times a day (2400mg/day). (b) During the 21 days after stopping the treatment with gabapentin. VAS 0–10:

    Mean daily pain scores. (a) During the 21 days of treatment with 800mg of oral gabapentin three times a day (2400mg/day). (b) During the 21 days after stopping the treatment with gabapentin. VAS 0–10: 0, no pain; 10, worst pain possible. Gabapentin: gabapentin group (n=10). Control: retrospective group (n=10). The boxes represent the 25th–75th percentiles, the dark line is the median; the extended bars represent the 10th–90th percentiles, and the circles represent values outside this range.

PII: S0305-4179(06)00152-5

doi: 10.1016/j.burns.2006.04.020

Burns
Volume 33, Issue 1 , Pages 81-86 , February 2007